Abstract
Objective
Src is a protein tyrosine kinase that plays important roles in cancer development, and Src kinase activity has been found to be elevated in several types of cancers. However, the cause of the elevation of Src kinase activity in the majority of human colon carcinomas is still largely unknown. We aim at finding the cause of elevated Src kinase activity in human colon carcinomas.
Methods
We employed normal colon epithelial FHC cells and examined Src activation in human colon carcinoma specimens from 8 patients. Protein expression levels were determined by Western blotting, and the activity of Src kinase by kinase assay.
Results
Actin levels were different between tumor and normal tissues, demonstrating the complexities and inhomogeneities of the tissue samples. Src kinase activities were increased in the majority of the colon carcinomas as compared with normal colon epithelial cells (range 13–29). Src protein levels were reduced in the colon carcinomas. Src Y530 phosphorylation levels were reduced to a higher extent than protein levels in the carcinomas.
Conclusion
The results suggest that Src specific activities were highly increased in human colon carcinomas; phosphorylation at Src Y530 was reduced, contributing to the highly elevated Src specific activity and Src kinase activity.
References
Wheeler DL, Iida M, Dunn EF. The role of Src in solid tumors. Oncologist 2009; 14:667–678.
Bolen JB, Veillette A, Schwartz AM, et al. Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 1987; 84:2251–2255.
Cartwright CA, Kamps MP, Meisler AI, et al. pp60c-src activation in human colon carcinoma. J Clin Invest 1989; 83:2025–2033.
Talamonti MS, Roh MS, Curley SA, et al. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 1993; 91:53–60.
Irby R, Mao W, Coppola D, et al. Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential. Cell Growth Differ 1997; 8: 1287–1295.
Staley CA, Parikh NU, Gallick GE. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth Differ 1997; 8:269–274.
Irby RB, Mao W, Coppola D, et al. Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 1999; 21:187–190.
Patwardhan P, Resh MD. Myristoylation and membrane binding regulate c-Src stability and kinase activity. Mol Cell Biol 2010; 30: 4094–4107.
Bjorge JD, Jakymiw A, Fujita DJ. Selected glimpses into the activation and function of Src kinase. Oncogene 2000; 19:5620–5635.
Zhu S, Bjorge JD, Fujita DJ. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res 2007; 67:10129–10137.
Hakak Y, Martin GS. Ubiquitin-dependent degradation of active Src. Curr Biol 1999; 9:1039–1042.
Iba H, Takeya T, Cross FR, et al. Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts. Proc Natl Acad Sci USA 1984; 81:4424–4428.
Parker RC, Varmus HE, Bishop JM. Expression of v-src and chicken c-src in rat cells demonstrates qualitative differences between pp60v-src and pp60c-src. Cell 1984; 37:131–139.
Shalloway D, Coussens PM, Yaciuk P. Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A 1984; 81:7071–7075.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by grants from the Alberta Cancer Board of Canada (2007-2010) to DJF.
An erratum to this article can be found at http://dx.doi.org/10.1007/s11670-011-0324-8
Rights and permissions
About this article
Cite this article
Zhu, Sd., Bjorge, J.D. & Fujita, D.J. Src is dephosphorylated at tyrosine 530 in human colon carcinomas. Chin. J. Cancer Res. 23, 229–231 (2011). https://doi.org/10.1007/s11670-011-0229-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11670-011-0229-6